HASBROUCK HEIGHTS, N.J., Nov. 14, 2011 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (Nasdaq:NYMX) announced today its financial results for the third quarter of 2011, prepared in accordance with International Financial Reporting Standards. Nymox reported a net loss of $1,614,041, or $0.05 per share for the quarter and $7,993,264, or $0.24 per share for the nine months ending September 30, 2011, compared to $1,649,061, or $0.05 per share for the quarter and $4,478,999 or $0.14 per share for the nine months ending September 30, 2010. Net losses include stock-based compensation charges of $3,943,338 in the nine month period ended September 30, 2011 and $406,542 in the comparative period in 2010. The increase in net losses is attributable primarily to higher stock-based compensation charges compared to 2010.
